Prevalence, Duration, Severity, and Distress of Chemotherapy-Related Gastrointestinal Symptoms in Patients With a Hematologic Malignancy

Purpose/Objectives: To describe prevalence, duration, severity, and distress of chemotherapy-related gastrointestinal (GI) symptoms, and evaluate inclusion of clinically relevant GI symptom items on cancer symptom questionnaires.

Design: Longitudinal descriptive design.

Setting: Inpatient and outpatient hematology settings.

Sample: 105 adults with a hematologic malignancy receiving their third or subsequent cycle of chemotherapy.